Download PDF
Thromb Haemost 2003; 89(03): 594-595
DOI: 10.1055/s-0037-1613393
Letters to the Editor
Schattauer GmbH

A reply to a rebuttal: The fibrinolytic system and obesity

Jane Hoover-Plow
Further Information

Publication History

Received 13 January 2003

Accepted 13 January 2003

Publication Date:
09 December 2017 (online)

    Permissions and Reprints

 

 

  • References

  • 1 Hoover-Plow J, Ellis J, Yuen L. In vivo plasminogen deficiency reduces fat accumulation. Thromb Haemost 2002; 87: 1011-9.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 2 Morange PE, Lijnen HR, Alessi MC, Kopp F, Collen D, Man-Vague I. Influence of PAI-1 on adipose tissue growth and metabolic parameters in a murine model of diet-induced obesity. ArteriosclerThromb Vasc Biol 2000; 20: 1150-4.
    CrossrefPubMedGoogle Scholar
  • 3 Morange PE, Bastelica D, Bonzi MF, Van HB, Collen D, Man-Vague I, Lijnen HR. Influence of t-pA and u-PA on adipose tissue development in a murine model of diet-induced obesity. Thromb Haemost 2002; 87: 306-10.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 4 Eren M, Su M, Atkinson J, King L, Declerck P, Vaughan D. Phenotypic derangements associated with overexpression of plasminogen activator inhibitor-1 (PAI-1) in transgenic mice. Arterioscler Thromb Vasc Biol 2002; 21: 695.
    PubMedGoogle Scholar
  • 5 Miskin R, Masos T. Transgenic mice overexposing urokinase-type plasminogen activator in the brain exhibit reduced food consumption, body weight and size, and increased longevity. J Gerontol 1997; 52A: B118-B124.
    CrossrefPubMedGoogle Scholar
  • 6 Hoover-Plow J, Yuen L. Plasminogen binding is increased with adipocyte differentiation. Biochem Biophys Res Commun 2001; 284: 389-94.
    CrossrefPubMedGoogle Scholar
  • 7 Mars WM, Zarnegar R, Michalopoulos GK. Activation of hepatocyte growth factor by the plasminogen activators uPA and tPA. Am J Pathol 1993; 143: 949-58.
    PubMedGoogle Scholar
  • 8 Stepanova V, Mukhina S, Köhler E, Resink TJ, Erne P, Tkachuk VA. Urokinase plasminogen activator induces human smooth muscle cell migration and proliferation via distinct receptor-dependent and proteolysis-dependent mechanisms. Mol Cell Biochem 1999; 195: 199-206.
    CrossrefPubMedGoogle Scholar
  • 9 Waltz DA, Fujita RM, Yang X, Natkin L, Zhuo S, Gerard CJ, Rosenberg S, Chapman HA. Nonproteolytic role for the urokinase receptor in cellular migration in vivo. Am J Respir Cell Mol Biol 2000; 22: 316-22.
    CrossrefPubMedGoogle Scholar
  • 10 Yepes M, Sandkvist M, Coleman TA, Moore E, Wu JY, Mitola D, Bugge TH, Lawrence DA. Regulation of seizure spreading by neu-roserpin and tissue-type plasminogen activator is plasminogen-independent. J Clin Invest 2002; 109: 1571-8.
    CrossrefPubMedGoogle Scholar
  • 11 Urano T, Kojima Y, Takahashi M, Serizawa K, Sakakibara K, Takada Y, Takada A. Impaired fibrinolysis in hypertension and obesity due to high plasminogen activator inhibitor-1 level in plasma. Jpn J Physiol 1993; 43: 221-8.
    CrossrefPubMedGoogle Scholar
  • 12 Man-Vague I, Alessi MC, Morange PE. Hypofibrinolysis and increased PAI-1 are linked to atherothrombosis via insulin resistance and obesity. Ann Med 2000; 32: 78-84.
    PubMedGoogle Scholar
  • 13 McGill JB, Schneider DJ, Arfken CL, Lucore CL, Sobel BE. Factors responsible for impaired fibrinolysis in obese subjects and NIDDM patients. Diabetes 1994; 43: 104-9.
    CrossrefPubMedGoogle Scholar
  • 14 Cigohni M, Targher G, Bergamo TIA, Tonoli M, Agostino G, De Sandre G. Visceral fat accumulation and its relation to plasma hemostatic factors in healthy men. Arterioscler Thromb Vasc Biol 1996; 16: 368-74.
    CrossrefPubMedGoogle Scholar
  • 15 Schafer K, Fujisawa K, Konstantinides S, Loskutoff DJ. Disruption of the plasminogen activator inhibitor 1 gene reduces the adiposity and improves the metabolic profile of genetically obese and diabetic ob/ob mice. FASEB J 2001; 15: 1840-2.
    CrossrefPubMedGoogle Scholar